Man Group plc Raises Position in CME Group Inc. (NASDAQ:CME)

Man Group plc raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 13.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 192,020 shares of the financial services provider's stock after purchasing an additional 22,049 shares during the period. Man Group plc owned 0.05% of CME Group worth $44,593,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. SJS Investment Consulting Inc. raised its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after buying an additional 97 shares during the period. New Age Alpha Advisors LLC raised its holdings in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the period. Financial Life Planners purchased a new stake in shares of CME Group in the fourth quarter worth approximately $32,000. Knuff & Co LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $33,000. Finally, Banque Transatlantique SA bought a new position in CME Group in the fourth quarter worth approximately $35,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director now directly owns 2,915 shares in the company, valued at approximately $790,781.20. The trade was a 25.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This trade represents a 12.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,134 shares of company stock worth $6,087,434 in the last 90 days. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Down 0.8%

CME Group stock opened at $266.28 on Thursday. The stock has a market capitalization of $95.96 billion, a price-to-earnings ratio of 27.54, a PEG ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business has a fifty day moving average price of $265.31 and a 200-day moving average price of $246.39. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.50 EPS. Equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.88%. CME Group's payout ratio is currently 50.30%.

Analysts Set New Price Targets

CME has been the topic of several research analyst reports. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Erste Group Bank raised CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Bank of America lifted their price target on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Finally, UBS Group lifted their price target on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.